Danavish Metformin+Voglibose 500mg/0.3mg Tablet SR
Marketer
Danavish Healthcare
Salt Composition
Metformin (500mg) + Voglibose (0.3mg)
Overview Danavish Metformin+Voglibose 500mg/0.3mg Tablet SR
Danavish Metformin/Voglibose 500mg/0.3mg extended-release tablets are antidiabetic medications, a combination therapy for adult type 2 diabetes. This treatment helps regulate blood glucose. Administer this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly influence diabetes control. Possible side effects include nausea, altered taste, appetite changes, gas, abdominal discomfort, diarrhea, and skin reactions. These are usually transient. Report persistent or concerning side effects to your doctor, who can offer management strategies. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.
Primary Ingredients of Danavish Metformin+Voglibose 500mg/0.3mg Tablet SR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Danavish Metformin+Voglibose 500mg/0.3mg Tablet SR
Managing type 2 diabetes
Major Benefits of Danavish Metformin+Voglibose 500mg/0.3mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Danavish Metformin+Voglibose 500mg/0.3mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Danavish Metformin+Voglibose 500mg/0.3mg Tablet SR:
- Flatulence
- Diarrhea
- Abdominal pain
- Vomiting
- Decreased appetite
How to use Danavish Metformin+Voglibose 500mg/0.3mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Danavish Metformin+Voglibose 500mg/0.3mg Tablet SR. Ingest the tablet whole; do not chew, crush, or divide it. Administer this medication with a meal.
How Danavish Metformin+Voglibose 500mg/0.3mg Tablet SR works:
Danavish SR tablets, containing 500mg metformin and 0.3mg voglibose, offer a dual-action approach to blood sugar management.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Danavish Metformin+Voglibose 500mg/0.3mg SR tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Danavish Metformin+Voglibose 500mg/0.3mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Consult your doctor for advice.
Breast feedingCONSULT YOUR DOCTOR
The combined medication Danavish Metformin+Voglibose 500mg/0.3mg Tablet SR is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Danavish Metformin+Voglibose 500mg/0.3mg SR Tablets. Nevertheless, individuals taking this medication should be aware of the potential for low blood sugar (hypoglycemia), particularly when used concurrently with other diabetes medications like sulfonylureas, insulin, or repaglinide.
KidneyCAUTION
Patients with kidney impairment should use Danavish Metformin+Voglibose 500mg/0.3mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Danavish Metformin/Voglibose 500mg/0.3mg extended-release tablets in individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Danavish Metformin+Voglibose 500mg/0.3mg Tablet SR :
Should you forget to take your Danavish Metformin+Voglibose 500mg/0.3mg Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Danavish Metformin+Voglibose 500mg/0.3mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently